| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DOCU | Common Stock | Sale | -$9.28M | -35.8K | -5.11% | $259.56 | 664K | Jun 17, 2021 | See footnotes | F1, F2, F3 |
| transaction | DOCU | Common Stock | Sale | -$443K | -1.7K | -0.26% | $260.07 | 663K | Jun 17, 2021 | See footnotes | F1, F2, F4 |
| transaction | DOCU | Common Stock | Options Exercise | $37.5K | +17.5K | +11.7% | $2.14 | 167K | Jun 17, 2021 | Direct | |
| transaction | DOCU | Common Stock | Sale | -$4.21M | -16.2K | -9.67% | $260.48 | 151K | Jun 17, 2021 | Direct | F5 |
| transaction | DOCU | Common Stock | Sale | -$349K | -1.34K | -0.89% | $261.09 | 150K | Jun 17, 2021 | Direct | F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DOCU | Option (Right to Buy) | Options Exercise | $0 | -17.5K | -43.75% | $0.00 | 22.5K | Jun 17, 2021 | Common Stock | 17.5K | $2.14 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | Represents shares of Common Stock held directly by BCIP Venture Associates ("BCIP Venture"), BCIP Venture Associates-B ("BCIP Venture-B"), BCIP Venture Associates II, L.P. ("BCIP Venture II"), BCIP Venture Associates II-B, L.P. ("BCIP Venture II-B"), Bain Capital Venture Fund 2014, L.P. ("BCV Fund 2014"), Bain Capital Venture Partners 2014, L.P. ("BCV Partners 2014"), Bain Capital Venture Coinvestment Fund, L.P. ("BCV Coinvestment Fund") and Bain Capital Venture Coinvestment Partners, L.P. ("BCV Coinvestment Partners" and, collectively, the "Bain Capital Venture Entities"). |
| F2 | Bain Capital Venture Investors, LLC ("BCVI") is (i) the general partner of each of BCV Partners 2014, which is the general partner of BCV Fund 2014, and BCV Coinvestment Partners, which is the general partner of BCV Coinvestment Fund, and (ii) governs the investment strategy and decision-making process with respect to investment held by each of BCIP Venture, BCIP Venture-B, BCIP Venture II and BCIP Venture II-B. Mr. Salem is a member of the Executive Committee and a Managing Director of BCVI. By virtue of the relationships described in this footnote, Mr. Salem may be deemed to share voting and dispositive power with respect to all of the shares of Common Stock held by the Bain Capital Venture Entities. Mr. Salem disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.00 to $259.995, inclusive. The reporting person undertakes to provide to DocuSign, Inc., any security holder of DocuSign, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (6) to this Form 4. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.00 to $260.09, inclusive. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.06 to $261.055, inclusive. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.06 to $261.122, inclusive. |
| F7 | This stock option was fully vested on the transaction date. |